Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Current approaches to treating and managing MGUS

Nelson Leung • 28 Sep 2023
IMS 2023
General

In this video, Nelson Leung, MD, Mayo Clinic, Rochester, MN, explains that patients with monoclonal gammopathy of undetermined significance (MGUS) are treated and managed with close observation, and further highlights current research looking to identify biomarkers of progression. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Nelson Leung

1:51
Diagnosis and potential therapeutic options for AA amyloidosis
Nelson Leung • 28 Sep 2023
1:22
Addressing nephrotoxicity in agents commonly used to treat multiple myeloma
Nelson Leung • 28 Sep 2023
0:58
Understanding the concept of MGRS
Nelson Leung • 28 Sep 2023
1:41
Optimal management of MGCS-related disorders
Nelson Leung • 25 Aug 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals